Related references
Note: Only part of the references are listed.State-of-the-art in the management of locally advanced and metastatic gallbladder cancer
Mairead G. McNamara et al.
CURRENT OPINION IN ONCOLOGY (2013)
Nicotinamide Inhibits Vasculogenic Mimicry, an Alternative Vascularization Pathway Observed in Highly Aggressive Melanoma
Orit Itzhaki et al.
PLOS ONE (2013)
Zoledronic acid inhibits vasculogenic mimicry in murine osteosarcoma cell line in vitro
Dehao Fu et al.
BMC MUSCULOSKELETAL DISORDERS (2011)
Inhibition of tumor growth and vasculogenic mimicry by cucumin through downregulation of the EphA2/PI3K/MMP pathway in a murine choroidal melanoma model
Lu-Xia Chen et al.
CANCER BIOLOGY & THERAPY (2011)
A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro
Wei Sun et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Norcantharidin induces cell cycle arrest and inhibits progression of human leukemic Jurkat T cells through mitogen-activated protein kinase-mediated regulation of interleukin-2 production
Hui-Fen Liao et al.
TOXICOLOGY IN VITRO (2011)
Involvement of mitochondrial pathway in NCTD-induced cytotoxicity in human hepG2 cells
Cheng Chang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Vasculogenic Mimicry: a New Prognostic Sign of Gastric Adenocarcinoma
Man Li et al.
PATHOLOGY & ONCOLOGY RESEARCH (2010)
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Carol Kilkenny et al.
PLOS BIOLOGY (2010)
Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy
Yue-Zu Fan et al.
WORLD JOURNAL OF GASTROINTESTINAL SURGERY (2010)
Trends in Presentation and Survival for Gallbladder Cancer During a Period of More Than 4 Decades A Single-Institution Experience
Ioannis T. Konstantinidis et al.
ARCHIVES OF SURGERY (2009)
Factors Influencing Long-Term Survival in Patients with T3 Gallbladder Adenocarcinoma
K. Dilip Chakravarty et al.
DIGESTION (2009)
Prognostic Role of Vasculogenic Mimicry in Colorectal Cancer
Coen I. M. Baeten et al.
DISEASES OF THE COLON & RECTUM (2009)
Biological mechanisms of bevacizumab-associated adverse events
Gerald M. Higa et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Effect of Genistein on vasculogenic mimicry formation by human uveal melanoma cells
Rihong Cong et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Norcantharidin is a small-molecule synthetic compound with anti-angiogenesis effect
Yu-Jen Chen et al.
LIFE SCIENCES (2009)
Surgical Management of Gallbladder Cancer
Srinevas K. Reddy et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2009)
Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma
Shiwu Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
Norcantharidin inhibits DNA replication and induces apoptosis with the cleavage in initiation protein Cdc6 in HL-60 cells
Jin-Long Li et al.
ANTI-CANCER DRUGS (2006)
Focal adhesion kinase signaling and the aggressive melanoma phenotype
Angela R. Hess et al.
CELL CYCLE (2006)
Focal adhesion kinase promotes the aggressive melanoma phenotype
AR Hess et al.
CANCER RESEARCH (2005)
Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells
Yue-Zu Fan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Functional role of matrix metalloproteinases in ovarian tumor cell plasticity
AK Sood et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
Norcantharidin induces human melanoma A375-S2 cell apoptosis through mitochondrial and caspase pathways
W An et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2004)
Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells
DWJ van der Schaft et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Chemotherapy in the treatment of advanced gallbladder cancer
H Ishii et al.
ONCOLOGY (2004)
Norcantharidin-induced apoptosis is via the extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells
YN Chen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Molecular plasticity of human melanoma cells
MJC Hendrix et al.
ONCOGENE (2003)
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
DM Brantley et al.
ONCOGENE (2002)
Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells
YN Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Vasculogenic mimicry and pseudo-comedo formation in breast cancer
K Shirakawa et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
PAS-positive loops and networks as a prognostic indicator in cutaneous malignant melanoma
A Thies et al.
JOURNAL OF PATHOLOGY (2001)
Epidemiology and molecular pathology of gallbladder cancer
EC Lazcano-Ponce et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2001)
Paxillin: a focal adhesion-associated adaptor protein
MD Schaller
ONCOGENE (2001)
Potential new antitumor agents from an innovative combination of demethylcantharidin, a modified traditional Chinese medicine, with a platinum moiety
YP Ho et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Norcantharidin-induced post-G2/M apoptosis is dependent on wild-type p53 gene
CY Hong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation
H Miao et al.
NATURE CELL BIOLOGY (2000)
Share Paper
